Cms posts final payment determination for bioaffinity technologies' cypath® lung effective january 2024

San antonio,--(business wire)-- #biaf--cms has made a final determination for payment for cypath® lung, a noninvasive test for early-stage lung cancer, for the 2024 calendar year.
BIAF Ratings Summary
BIAF Quant Ranking